New Study Reveals Two Genes Associated with High Risk for ALS

Genetic mutations in two previously unrecognized genes, the microtubule-associated protein tau (MAPT) and BNIP1 genes, are associated with elevated risk for amyotrophic lateral sclerosis (ALS). The study with that finding “Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum,” was published in the journal JAMA Neurology. As seen in other neurodegenerative diseases, abnormal accumulation of […]

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

March 8, 2018 – Servier, Pfizer Inc. (NYSE: PFE) and Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), today announced that results from the two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR T-cell product being developed by Servier and Pfizer, will be presented during the European society for Blood and Marrow Transplantation (EBMT) Annual Meeting […]

Digital Drug Development Services Provider Transparency Life Sciences Raises $5.0 Million in Series A Financing

New York, NY — February 15, 2018 — Transparency Life Sciences (TLS), a pioneer in digital drug development clinical services, today announced completion of a $5.0 million Series A financing led by venture investor New Ventures III. Existing private investors also participated. TLS will use the new financing to expand the company’s technology platform and […]

Global Angiopoietin 1 Receptor Market 2018 – Pfizer, Eddingpharm, Teva Pharmaceutical Industries Ltd

The Angiopoietin 1 Receptor Market 2018 Research Report studies an absolute and exhaustive study on Angiopoietin 1 Receptor industry volume, Market Share, Industry Trends, Angiopoietin 1 Receptor Growth appearances, the wide range of applications, Utilization ratio, Supply including demand analysis, production capacity, Price during the Forecast period from 2018 to 2023. High Use of Angiopoietin 1 Receptor […]